Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial
María Jesús Pérez-Granda, José María Barrio, Patricia Muñoz, Javier Hortal, Cristina Rincón, Pablo Martin Rabadán, Maria Sagrario Pernia, Emilio Bouza, María Jesús Pérez-Granda, José María Barrio, Patricia Muñoz, Javier Hortal, Cristina Rincón, Pablo Martin Rabadán, Maria Sagrario Pernia, Emilio Bouza
Abstract
Background: Lock-therapy with antimicrobials has been used for the treatment and prevention of catheter-related bloodstream infections (CR-BSI). Experiences with Ethanol-Locks (E-locks) have included therapeutic interventions with variable results. Patients undergoing Major Heart Surgery (MHS) are a high-risk population for CR-BSI.The aim of this study was to assess the efficacy and tolerance to E-Locks in the prevention of CR-BSI of patients undergoing MHS.
Methods and findings: This is an academic, prospective, randomized, non-blinded and controlled clinical trial assessing the incidence of CR-BSI of patients with E-locks (E-lock) and the tolerance to the procedure in comparison with patients receiving conventional catheter-care (CCC). Patients undergoing MHS with intravascular catheters for more than 48 hours were randomly assigned into treatment or control group by a computer-generated list of randomly assigned numbers. In the treatment group, all their catheter lumens were locked with an ethanol solution at 70% for two hours, every three days (E-Locks). The control group received conventional catheter-care (CCC). Overall, 200 patients with 323 catheters were included in the study, which was stopped after 10 months due to adverse events. Of them, 179 catheters (113 patients) had E-Locks and 144 catheters (87 patients) were CCC. Euroscore Surgical Risk in both groups was 4.04 vs 4.07 p = 0.94 respectively. The results for the E-Locks and CCC were as follows: Incidence of CR-BSI/1000 days of exposure 2.1 vs 5.2 (p = 0.33), catheter tip colonization 14 (7.8%) vs 6 (4.2%) patients (p = 0.17), median length of hospital stay, 15 vs 16 days (p = 0.77). Seven patients (6.19%), all in the ethanol branch, had to discontinue the trial due to intolerance or adverse events.
Conclusions: We do not recommend prophylaxis of CR-BSI with ethanol-lock on a routine basis in patients undergoing Major Heart Surgery.
Trial registration: Clinical Trials.gov NCT01229592.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, et al. (1997) The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 112: 666–675.
- Rebollo MH, Bernal JM, Llorca J, Rabasa JM, Revuelta JM (1996) Nosocomial infections in patients having cardiovascular operations: a multivariate analysis of risk factors. J Thorac Cardiovasc Surg 112: 908–913.
- Le Guillou V, Tavolacci MP, Baste JM, Hubscher C, Bedoit E, et al. (2011) Surgical site infection after central venous catheter-related infection in cardiac surgery. Analysis of a cohort of 7557 patients. J Hosp Infect 79: 236–241.
- Bouza E, San Juan R, Munoz P, Pascau J, Voss A, et al. (2004) A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). Clin Microbiol Infect 10: 838–842.
- Zack J (2008) Zeroing in on zero tolerance for central line-associated bacteremia. Am J Infect Control 36: : S176 e171–172.
- Kim JS, Holtom P, Vigen C (2011) Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control 39: 640–646.
- Betjes MG (2011) Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat Rev Nephrol 7: 257–265.
- Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, et al. (2006) An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355: 2725–2732.
- Palomar Martinez M, Alvarez Lerma F, Riera Badia MA, Leon Gil C, Lopez Pueyo MJ, et al. (2010) [Prevention of bacteriema related with ICU catheters by multifactorial intervention: a report of the pilot study]. Med Intensiva 34: 581–589.
- Opilla MT, Kirby DF, Edmond MB (2007) Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 31: 302–305.
- Kim EY, Saunders P, Yousefzadeh N (2010) Usefulness of anti-infective lock solutions for catheter-related bloodstream infections. Mt Sinai J Med 77: 549–558.
- Huang EY, Chen C, Abdullah F, Aspelund G, Barnhart DC, et al. (2011) Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 46: 2000–2011.
- Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, et al. (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5: 1799–1804.
- Rajpurkar M, Boldt-Macdonald K, McLenon R, Callaghan MU, Chitlur M, et al. (2009) Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients. Haemophilia 15: 1267–1271.
- Wales PW, Kosar C, Carricato M, de Silva N, Lang K, et al. (2011) Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience. J Pediatr Surg 46: 951–956.
- Oliveira C, Nasr A, Brindle M, Wales PW (2012) Ethanol Locks to Prevent Catheter-Related Bloodstream Infections in Parenteral Nutrition: A Meta-Analysis. Pediatrics.
- McGrath EJ, Salloum R, Chen X, Jiang Y, Boldt-MacDonald K, et al. (2011) Short-dwell ethanol lock therapy in children is associated with increased clearance of central line-associated bloodstream infections. Clin Pediatr (Phila) 50: 943–951.
- Broom J, Woods M, Allworth A, McCarthy J, Faoagali J, et al. (2008) Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis 40: 399–406.
- O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, et al. (2011) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 39: S1–34.
- Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296: 1305–1309.
- Weller C, McNeil J (2010) CONSORT 2010 statement: updated guidelines can improve wound care. J Wound Care 19: 347–353.
- Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, et al. (2004) Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32: 2014–2020.
- Patil HV, Patil VC, Ramteerthkar MN, Kulkarni RD (2011) Central venous catheter-related bloodstream infections in the intensive care unit. Indian J Crit Care Med 15: 213–223.
- van der Kooi TI, Wille JC, van Benthem BH (2012) Catheter application, insertion vein and length of ICU stay prior to insertion affect the risk of catheter-related bloodstream infection. J Hosp Infect 80: 238–244.
- Bouza E, Munoz P, Burillo A, Lopez-Rodriguez J, Fernandez-Perez C, et al. (2005) The challenge of anticipating catheter tip colonization in major heart surgery patients in the intensive care unit: are surface cultures useful? Crit Care Med 33: 1953–1960.
- Onder AM, Billings A, Chandar J, Francoeur D, Simon N, et al. (2010) PREFABL: predictors of failure of antibiotic locks for the treatment of catheter-related bacteraemia. Nephrol Dial Transplant 25: 3686–3693.
- Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, et al. (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47: 83–93.
- Ghannoum MA, Isham N, Jacobs MR (2011) Antimicrobial activity of B-Lock against bacterial and Candida spp. causing catheter-related bloodstream infections. Antimicrob Agents Chemother 55: 4430–4431.
- Venditto M, du Montcel ST, Robert J, Trystam D, Dighiero J, et al. (2010) Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purif 29: 268–273.
- Shenep LE, Shenep MA, Cheatham W, Hoffman JM, Hale A, et al. (2011) Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization. J Hosp Infect 79: 317–322.
- Blackwood RA, Klein KC, Micel LN, Willers ML, Mody RJ, et al. (2011) Ethanol locks therapy for resolution of fungal catheter infections. Pediatr Infect Dis J 30: 1105–1107.
- Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R (2007) Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51: 78–83.
- Valentine KM (2011) Ethanol lock therapy for catheter-associated blood stream infections in a pediatric intensive care unit. Pediatr Crit Care Med 12: e292–296.
- John BK, Khan MA, Speerhas R, Rhoda K, Hamilton C, et al... (2011) Ethanol Lock Therapy in Reducing Catheter-Related Bloodstream Infections in Adult Home Parenteral Nutrition Patients: Results of a Retrospective Study. JPEN J Parenter Enteral Nutr.
- Wong T, Clifford V, McCallum Z, Shalley H, Peterkin M, et al... (2011) Central Venous Catheter Thrombosis Associated With 70% Ethanol Locks in Pediatric Intestinal Failure Patients on Home Parenteral Nutrition: A Case Series. JPEN J Parenter Enteral Nutr.
- Slobbe L, Doorduijn JK, Lugtenburg PJ, El Barzouhi A, Boersma E, et al. (2010) Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 5: e10840.
- Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW (2012) A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients—the HEALTHY-CATH trial. BMC Nephrol 13: 146.
- Heng AE, Abdelkader MH, Diaconita M, Nony A, Guerraoui A, et al. (2011) Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction. Clin Nephrol 75: 534–541.
- Rodriguez-Creixems M, Munoz P, Martin-Rabadan P, Cercenado E, Guembe M, et al. (2013) Evolution and aetiological shift of catheter-related bloodstream infection in a whole institution: the microbiology department may act as a watchtower. Clin Microbiol Infect 19: 845–851.
- McCabe W, Jackson GG (1962) Gram-negative bacteremia, I: etiology and ecology. Arch Inter Med 110: 847–55.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373–383.
- Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, et al. (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16: 9–13.
Source: PubMed